Skip to main content
SpringerLink
Log in

Sialorrhea and Frey’s Syndrome

  • Chapter
Therapeutic Uses of Botulinum Toxin

  • 1270 Accesses

Abstract

With the widespread use of botulinum toxin (BTX) and greater appreciation of its safety, physicians are increasingly aware of potential applications beyond dystonias, spasticity, and cosmetic denervation. Although most applications for BTX have focused on muscular denervation, autonomic denervation is currently being explored for a variety of clinical problems including excessive drooling, gustatory sweating, and hyperlacrimation. This chapter focuses on the role of BTX for uncontrolled salivation and gustatory sweating.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Rossetto O, Seveso M, Caccin P, et al. Botulinum neurotoxins are metalloprotease specific for SNARE proteins involved in neuroexocytosis. In: Kreyden OP, Boni R, Burg G, eds. Hyperhidrosis and Botulinum Toxin in Dermatology. Basel: Karger; 2002, pp. 117–125.

    Chapter  Google Scholar 

  2. Kontis Y, Johns ME. Anatomy and physiology of the salivary glands. In: Bailey BJ, ed. Head and Neck Surgery—Otolaryngology. 3rd ed. New York: Lippincott Williams & Wilkins; 2001, pp. 429–436.

    Google Scholar 

  3. Sullivan PB, Lambert B, Rose M, Ford-Adams M, Johnson A, Griffiths P. Prevalence and severity of feeding and nutritional problems in children with neurological impariement: Oxford Feeding Study. Dev Med Child Neurol 2000;42:613–617.

    Article  Google Scholar 

  4. Harris SR, Purdy AH. Drooling and its management in cerebral palsy. Dev Med Child Neurol 1987;29:807–811.

    Article  PubMed  CAS  Google Scholar 

  5. Tahmassebi JF, Curzon ME. Prevalence of drooling in children with cerebral palsy attending special schools. Dev Med Chil Neurol 2003;45:613–617.

    Article  CAS  Google Scholar 

  6. Hyson HC, Johnson A, Jog MS. Survey of sialorrhea in parkinsonian patients in southwestern Ontario. Can J Neurol Sci 2001;28:S46–S47.

    Google Scholar 

  7. Bhidayasiri R, Truong D. Expanding use of botulinum toxin. J Neurol Sci 2005;235:1–9.

    Article  PubMed  CAS  Google Scholar 

  8. Volonte MA, Porta M, Comi G. Clinical assessment of dysphagia in early phases of Parkinson’s disease. Neurol Sci 2002;23:S121–S122.

    Article  PubMed  Google Scholar 

  9. Glickman S, Deaney CN. Treatment of relative sialorhoea with botulinum toxin type A: description and rationale for an injection procedure with case report. Eur J Neurol 2001;8:567–571.

    Article  PubMed  CAS  Google Scholar 

  10. Thomas-Stonell N, Greenberg J. Three treatment approaches and clinical factors in the reduction of drooling. Dysphagia 1988;3:73–78.

    Article  PubMed  CAS  Google Scholar 

  11. Reddihough D, Johnson H, Ferguson E. The role of a saliva control clinic in the management of drooling. J Paediatr Child Health 1992;28:395–397.

    PubMed  CAS  Google Scholar 

  12. Mier RJ, Bachrach SJ, Lakin RC, Barker T, Childs J, Moran M. Treatment of sialorhea with glycopyrrolate: a double-blind, dose-ranging study. Arch Pediatr Adolesc Med 2000; 154: 1214–1218.

    PubMed  CAS  Google Scholar 

  13. Talmi YP, Finkelstein Y, Zohar Y Reduction of salivary flow with transdermal scopolamine: a four year experience. Otolaryngol Head Neck Surg 1990;103:615–618.

    PubMed  CAS  Google Scholar 

  14. Frederick FJ, Stewart IF. Effectiveness of transtympanic neurectomy in management of sialorrhea occurring in mentally retarded patients. J Otolaryngol 1982; 11:289–292.

    PubMed  CAS  Google Scholar 

  15. Parisir SC, Blitzer A, Binder WA, Friedman WH. Tympanic neurectomy and chorda tympanectomy. Tran AAOO 1978;86:308–321.

    Google Scholar 

  16. Ethunandan M, Macpherson DW. Persistent drooling: treatment by bilateral sbmandibular duct transposition and simultaneous sublingual gland excision. An R Coll Surg Engl 1998;80: 279–282.

    CAS  Google Scholar 

  17. Shott SR, Myer CM, Cotton RT. Surgical management of sialorrhea. Otolaryngol Head Neck Surg 1989; 101:47–50.

    PubMed  CAS  Google Scholar 

  18. Mankarious LA, Bottrill IA, Huchzermyer PM, Bailey CM. Long-term follow up of submandibular duct rerouting for the treatment of sialorrhea in the pediatrie population. Otolaryngol Head Neck Surg 1999;120:303–307.

    Article  PubMed  CAS  Google Scholar 

  19. Borg M, Hirst F. The role of radiation therapy in the management of sialorrhea. Int J Raol Oncol Biol Phys 1998;41:1113–1119.

    Article  CAS  Google Scholar 

  20. Jongerius PH, van den Hoogen JA, Limbeek J, Gabreels FJ, van Hulst K, Rottevell JJ. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial. Pediatrics 2004; 114: 620–627.

    Article  PubMed  Google Scholar 

  21. Brin MF, Lew MF, Adler CH, et al. Safety and efficacy of NeurobBloc (botulinum toxin type B) for type A-resistant cervical dystonia. Neurology 1999;53:1431–1438. 135

    PubMed  CAS  Google Scholar 

  22. Comella CL, Jankovic J, Shannon KM, et al. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 2005;65:1423–1429.

    Article  PubMed  CAS  Google Scholar 

  23. Ellies M, Gottstein U, Rohrbach-Volland S, Arglebe C, Laskawa R. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis. Laryngoscope 2004; 114:1856–1860.

    Article  PubMed  CAS  Google Scholar 

  24. Turk-Gonzales M, Odderson IR. Quantitative reduction of saliva production with botulinum toxin type B injection into the salivary glands. Neurorehabil Neural Repair 2005;19:58–61.

    Article  PubMed  Google Scholar 

  25. Frey L. Le syndrome du nerf auricuo-temporal. Rev Neurol 1923;2:97–114.

    Google Scholar 

  26. Arad A, Blitzer A. Botulinum toxin in the treatment of autonomic system disorders. Op Tech in Otolaryngol and Head and Neck Surg 2004;15:118–121.

    Article  Google Scholar 

  27. Drobik C, Laskawi R. Frey’s syndrome: treatment with botulinum toxin. Acta Otolaryngol (Stockh) 1995;115:459–461.

    CAS  Google Scholar 

  28. Laskawi R, Schott T, Schroder M. Recurrent pleomorphic adenomas of the arotid gland: Clinical evaluation and long term follow-up. Br J Oral Maxillofac Surg 1998;36:48–51.

    Article  PubMed  CAS  Google Scholar 

  29. Shaw JE, Parker R, Hollis S, Gokal R, Boulton ATM. Gustatory sweating in diabetes mellitus. Diab Med 1996;13:1033–1037.

    Article  CAS  Google Scholar 

  30. Kreyden OP, Scheidegger EP. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis. Clinics in Derm 2004;22:40–44.

    Article  Google Scholar 

  31. Sinha UK, Saadat D, Doherty CM, Rice DH. Use of AlloDerm implant to prevent Frey syndrome after parotidectomy. Arch Facial Plast Surg 2003;5:109–112.

    Article  PubMed  Google Scholar 

  32. May M. Microanatomy and pathophysiology. In: May M, Schaitkin BM, eds. The Facial Nerve. 2nd ed. New York: Thieme; 2000, pp. 57–65.

    Google Scholar 

  33. Urman JD, Bobrove AM. Diabetic gustatory sweating successful treatment with topical glycopyrrolate: report of a case and review of the literature. Arch Intern Med 1999;159:877–878.

    Article  PubMed  CAS  Google Scholar 

  34. Arad-Cohen A, Blitzer A. Botulinum toxin treatment for symptomatic Frey’s syndrome Otolaryngol Head Neck Surg 2000; 122:237–240.

    Article  PubMed  CAS  Google Scholar 

  35. Restivo DA, Lanza S, Patti F, et al. Improvement of diabetic autonomie gustatory sweating by botulinum toxin type A. Neurolog 2002;59:1971–1973.

    CAS  Google Scholar 

  36. Naumann M, Zellner M, Toyka KV, Reiners K. Treatment of gustatory sweating with botulinum toxin. Ann Neurol 1997;42:973–975.

    Article  PubMed  CAS  Google Scholar 

  37. Laskawi R, Drobik C, Schonebeck C. Up to date report of botulinum toxin type A treatment in patients with gustatory sweating (Frey’s syndrome). Laryngoscope 1998;108:381–384.

    Article  PubMed  CAS  Google Scholar 

  38. Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia D, Brasnu D, Bonan B. Recurrent gustatory sweating (Frey Syndrome) after intracutaneous injection of botulinum toxin type A. Arch Otolaryngol Head Neck Surg 1999;125:282–286.

    Google Scholar 

  39. Bjerkhoel A, Trobbe O. Frey’s syndrome: treatment with botulium toxin. J Laryngol Otol 1997;lll:839–844.

    Google Scholar 

  40. Arad-Cohen A, Blitzer A. Botulinum toxin treatment for symptomatic Frey’s syndrome. Otolaryngol Head and Neck Surg 2000;122:237–240.

    Article  CAS  Google Scholar 

Download references

Authors
  1. Phillip Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jerome S. Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrew Blitzer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Physical Medicine and Rehabilitation New York Presbyterian Hospital, The University Hospital of Columbia and Cornell, New York, NY

    Grant Cooper MD

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this chapter

Cite this chapter

Song, P., Schwartz, J.S., Blitzer, A. (2007). Sialorrhea and Frey’s Syndrome. In: Cooper, G. (eds) Therapeutic Uses of Botulinum Toxin. Humana Press. https://doi.org/10.1007/978-1-59745-247-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-247-2_9

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-914-7

  • Online ISBN: 978-1-59745-247-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation